{
  "id": 1964341,
  "title": "Moderna’s cancer shot: exciting for investors, inconclusive for patients",
  "url": "https://urgent.news/2026/08/19/modernas-cancer-shot-exciting-for-investors-inconclusive-for-patients",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-19T14:33:20.000Z",
  "source": {
    "name": "Financial Times",
    "slug": "financial-times",
    "url": "https://www.ft.com/content/d8ff1233-01ff-496d-aa18-91233c1db051"
  },
  "original_language": "en",
  "account": null,
  "summary": "A glimmer of hope for sufferers, a potential revenue platform for a cash-burner, and a whole heap of unknowns",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Newsweek",
        "title": "Moderna Cancer Trial Success Is a Shot in the Arm for Trump",
        "url": "https://urgent.news/2026/08/19/moderna-cancer-trial-success-is-a-shot-in-the-arm-for-trump",
        "published": "2026-08-19T13:12:50.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}